Works matching DE "PHARMACEUTICAL reference pricing"

Results: 37

High costs for seniors.

Published in:

Fraser Forum, 2009, p. 24

By:

Skinner, Brett J.;
Rovere, Mark

Publication type:

Article

The wrong answer to high drug prices.

Published in:

Fraser Forum, 2009, p. 7

By:

Stevens, Philip

Publication type:

Article

Top 10 drugs.

Published in:: Australian Prescriber, 2010, v. 33, n. 6, p. 181, doi. 10.18773/austprescr.2010.085
Publication type:: Article

Your questions to the PBAC.

Published in:

Australian Prescriber, 2010, v. 33, n. 5, p. 144

By:

Khalil, Hanan

Publication type:

Article

Evaluación positiva de medicamentos: septiembre, octubre y noviembre de 2023.

Published in:

Sanidad Militar, 2023, v. 79, n. 4, p. 272, doi. 10.4321/S1887-85712023000400010

By:

Silva-Cuevas, M. A.;
García-Luque, A.;
Sánchez-de-Castro, M.;
Heinz-Morán, S.

Publication type:

Article

Recent Developments in Health Law.

Published in:

Journal of Law, Medicine & Ethics, 2011, v. 39, n. 2, p. 291, doi. 10.1111/j.1748-720X.2011.00599.x

By:

Darrow, Jonathan J.;
Chilton, Adam

Publication type:

Article

The perverse impact of external reference pricing (ERP): a comparison of orphan drugs affordability in 12 European countries. A call for policy change.

Published in:

Journal of Market Access & Health Policy, 2017, v. 5, n. 1, p. N.PAG, doi. 10.1080/20016689.2017.1369817

By:

Young, K. E.;
Soussi, I.;
Toumi, M.

Publication type:

Article

Crimes against humanity.

Published in:

Rhode Island Medical Journal, 2017, v. 100, n. 6, p. 8

By:

FRIEDMAN, JOSEPH H.

Publication type:

Article

Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia.

Published in:

PLoS Medicine, 2007, v. 4, n. 3, p. 0466, doi. 10.1371/journal.pmed.0040082

By:

Ud Din Babar, Zaheer;
Mohamed Ibrahim, Mohamed Izham;
Singh, Harpal;
Bukahri, Nadeem Irfan;
Creese, Andrew

Publication type:

Article

"For the strength of the pack is the wolf, and the strength of wolf is the pack".

Published in:

SA Pharmaceutical Journal Incorporating Pharmacy Management, 2017, v. 84, n. 4, p. 6

By:

Malan, Sarel

Publication type:

Article

Clinician attitudes towards prescribing and implications for interventions in a multi-specialty group practice.

Published in:

Journal of Evaluation in Clinical Practice, 2008, v. 14, n. 6, p. 969, doi. 10.1111/j.1365-2753.2007.00913.x

By:

Fortuna, Robert J.;
Ross‐Degnan, Dennis;
Finkelstein, Jonathan;
Zhang, Fang;
Campion, Francis X.;
Simon, Steven R.

Publication type:

Article

No matter who wins, pharmacy will lose.

Published in:

2013

By:

Greenwood, Stephen

Publication type:

Opinion

The growth imperative: preparing for a changing tide in pharmacy profitability.

Published in:

Australian Journal of Pharmacy, 2010, v. 91, n. 1086, p. 8

By:

Annabel, Bruce

Publication type:

Article

Pharmacy Benefit Managers, Rebates, and Drug Prices: Conflicts of Interest in the Market for Prescription Drugs.

Published in:

Yale Law & Policy Review, 2020, v. 38, n. 2, p. 360

By:

Shepherd, Joanna

Publication type:

Article

Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.

Published in:

Pharmacy World & Science, 2008, v. 30, n. 1, p. 57

By:

Jana Davidova;
Lenka Praznovcova

Publication type:

Article

Differential pricing for pharmaceuticals: reconciling access, R&D and patents.

Published in:

2003

By:

Danzon, Patricia;
Towse, Adrian;
Danzon, Patricia M

Publication type:

journal article

Low-Cost Pharma.

Published in:

National Medical Journal of India, 2018, v. 31, n. 3, p. 176, doi. 10.4103/0970-258x.255764

By:

ANAND, ANIL C.

Publication type:

Article

The international drug price indicator guide: An objective source of information about medicine prices.

Published in:

Indian Journal of Pharmacology, 2014, v. 46, n. 6, p. 662, doi. 10.4103/0253-7613.144949

By:

Pathiyil Ravi Shankar

Publication type:

Article

Indication-Specific Pricing for Cancer Drugs.

Published in:

2014

By:

Bach, Peter B.

Publication type:

Opinion

Innovation-Innovation Tradeoffs in Drug Pricing.

Published in:

2016

By:

Sachs, Rachel E.;
Frakt, Austin B.

Publication type:

journal article

Copay Assistance for Expensive Drugs: A Helping Hand That Raises Costs.

Published in:

2016

By:

Ubel, Peter A.;
Bach, Peter B.

Publication type:

journal article

A drug cost model for injuries due to road traffic accidents.

Published in:

Pharmacy Practice (1886-3655), 2008, v. 6, n. 1, p. 9, doi. 10.4321/S1886-36552008000100002

By:

Riewpaiboon, Arthorn;
Piyauthakit, Piyanuch;
Srijariya, Witsanuchai;
Chaikledkaew, Usa

Publication type:

Article

Pricing matrix model: dealing with uncertainty.

Published in:

2007

By:

Nuijten, Mark J. C.

Publication type:

journal article

Grenzen der Zulässigkeit und der Ausgestaltung von Preismodellen für Arzneimittel im Erstattungskodex.

Published in:

Journal für Medizin- und Gesundheitsrecht (JMG), 2020, n. 3, p. 143, doi. 10.37942/jmg202003014301

By:

Ernst, Gisela

Publication type:

Article

How Reference Pricing for Pharmaceuticals Can Increase Generic Share of Market: The Slovenian Experience.

Published in:

Journal of Public Policy & Marketing, 2007, v. 26, n. 1, p. 89, doi. 10.1509/jppm.26.1.89

By:

Podnar, Klement;
Molj, Bojan;
Golob, Urs̆a

Publication type:

Article

The dilemma of high drug prices.

Published in:

2015

By:

Wertheimer, Albert

Publication type:

Editorial

Proposed methodology for monitoring antiretroviral drugs price negotiations in Latin America and the Caribbean.

Published in:

Pan American Journal of Public Health / Revista Panamericana de Salud Pública, 2009, v. 26, n. 2, p. 137, doi. 10.1590/S1020-49892009000800006

By:

Osorio-de-Castro, Claudia G. S.;
Crisante, Maruja;
Miranda, Elaine S.;
Oliveira, Egléubia A.;
Oliveira, Maria A.

Publication type:

Article

Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018.

Published in:

2020

By:

Hernandez, Inmaculada;
San-Juan-Rodriguez, Alvaro;
Good, Chester B.;
Gellad, Walid F.

Publication type:

journal article

Rebates-The Little-Known Factor Behind Increasing Drug List Prices.

Published in:

2020

By:

Rubin, Rita

Publication type:

journal article

The EpiPen Problem: Analyzing Unethical Drug Price Increases and the Need for Greater Government Regulation.

Published in:

University of Miami Business Law Review, 2017, v. 26, n. 1, p. 129

By:

Rashid, Talal

Publication type:

Article

Value-Based Pricing: L'Enfant Terrible?

Published in:

2018

By:

Garner, Sarah;
Rintoul, Andrew;
Hill, Suzanne;
Hill, Suzanne R

Publication type:

Letter

Cost Effectiveness of Dabrafenib as a First-Line Treatment in Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma in Canada.

Published in:

PharmacoEconomics, 2015, v. 33, n. 4, p. 367, doi. 10.1007/s40273-014-0241-z

By:

Delea, Thomas;
Amdahl, Jordan;
Wang, Alice;
Amonkar, Mayur;
Thabane, Marroon

Publication type:

Article

PPMA urges PM to sign Drug Prices Summary sent by DRAP.

Published in:: Pulse International, 2017, v. 18, n. 15, p. 8
Publication type:: Article

Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States.

Published in:

Croatian Medical Journal, 2011, v. 52, n. 2, p. 183, doi. 10.3325/cmj.2011.52.183

By:

Vogler, Sabine;
Habl, Claudia;
Bogut, Martina;
Vončina, Luka

Publication type:

Article

Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.

Published in:

Health Policy & Planning, 2010, v. 25, n. 3, p. 219, doi. 10.1093/heapol/czp056

By:

Hao Yang;
Dib, Hassan H.;
Minmin Zhu;
Gang Qi;
Xinping Zhang

Publication type:

Article

From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy.

Published in:

PharmacoEconomics - Open, 2024, v. 8, n. 2, p. 251, doi. 10.1007/s41669-023-00467-2

By:

Rossini, Elvio Emanuele;
Galeone, Carlotta;
Lucchetti, Chiara;
Jommi, Claudio

Publication type:

Article

Drug-resistant TB and HIV in resource-limited settings: what TB/HIV programmes can learn from each other.

Published in:

Tropical Medicine & International Health, 2008, v. 13, n. 9, p. 1204, doi. 10.1111/j.1365-3156.2008.02127.x

By:

Colebunders, R.;
Worodria, W.;
Jones-López, E.;
Joloba, M.;
Apers, L.;
Ellner, J.

Publication type:

Article